NCT05731414 Outcomes From Remediation and Behavioural Intervention Techniques
| NCT ID | NCT05731414 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Toronto |
| Condition | Schizophrenia |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2023-03-01 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is currently unknown what factors predict response to Cognitive Behavioural Therapy for Psychosis (CBTp) or Cognitive Remediation Therapy (CR) among individuals with schizophrenia-spectrum disorders, thus the current trial will examine predictors of response to determine who requires the combined intervention and who might respond sufficiently to either monotherapy.
Eligibility Criteria
Inclusion Criteria: * Aged 18-65 years * Diagnosed with schizophrenia-spectrum disorders * Can read, write, and speak English Exclusion Criteria: * Neurodevelopmental disability or neurocognitive disorder * CBT or CR in the past 6 months
Contact & Investigator
Michael W Best, PhD, C.Psych
PRINCIPAL INVESTIGATOR
University of Toronto Scarborough
Frequently Asked Questions
Who can join the NCT05731414 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Schizophrenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05731414 currently recruiting?
Yes, NCT05731414 is actively recruiting participants. Contact the research team at hanna.hamzai@mail.utoronto.ca for enrollment information.
Where is the NCT05731414 trial being conducted?
This trial is being conducted at Scarborough Village, Canada, Whitby, Canada.
Who is sponsoring the NCT05731414 clinical trial?
NCT05731414 is sponsored by University of Toronto. The principal investigator is Michael W Best, PhD, C.Psych at University of Toronto Scarborough. The trial plans to enroll 360 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.